The Unintended Consequences of National Pharmacare Programs in Australia, New Zealand and the UK

Lessons from the U.K., New Zealand and Australia indicate that government-run pharmacare limits access to new drugs, discourages innovation

By Fraser Institute —— Bio and Archives--December 13, 2018

Canadian News, Politics | Comments | Back To Full Article

VANCOUVER—As Canadian policymakers grapple with a potential national pharmacare program, we should learn from the United Kingdom, Australia and New Zealand where publicly-funded pharmacare schemes have resulted in reduced access to new drugs for patients, drug shortages, higher taxes and less pharmaceutical innovation, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Comments

---

Support Canada Free Press

---

---

Recommended by Canada Free Press

---

---

---